Bokf, Na Biomarin Pharmaceutical Inc Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$74.43 - $92.22 $27,911 - $34,582	375 New	375 $30,000
Q2 2023 Aug 21, 2023	SELL	$86.68 - $100.3 $27,304 - $31,594	-315 Reduced 45.65%	375 $32,000
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $60,540 - $80,916	690 New	690 $67,000
Q3 2021 Nov 10, 2021	SELL	$74.77 - $85.47 $1.06 Million - $1.21 Million	-14,214 Closed	0 $0
Q1 2021 Apr 21, 2021	BUY	$74.73 - $90.69 $24,735 - $30,018	331 Added 2.38%	14,214 $1.07 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $100,201 - $124,476	1,380 Added 11.04%	13,883 $1.22 Million
Q3 2020 Oct 30, 2020	SELL	$71.87 - $131.03 $421,805 - $769,015	-5,869 Reduced 31.95%	12,503 $951,000
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $90,050 - $140,617	1,132 Added 6.57%	18,372 $2.27 Million
Q1 2020 May 13, 2020	SELL	$71.37 - $96.85 $388,538 - $527,251	-5,444 Reduced 24.0%	17,240 $1.46 Million
Q4 2019 Feb 12, 2020	SELL	$64.27 - $86.37 $677,534 - $910,512	-10,542 Reduced 31.73%	22,684 $1.92 Million
Q3 2019 Nov 13, 2019	BUY	$67.4 - $85.11 $110,401 - $139,410	1,638 Added 5.19%	33,226 $2.24 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $907,231 - $1.06 Million	-11,291 Reduced 26.33%	31,588 $2.71 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $721,173 - $844,680	8,565 Added 24.96%	42,879 $3.81 Million
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $809,093 - $1.07 Million	-10,096 Reduced 22.73%	34,314 $2.92 Million
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $2.79 Million - $3.14 Million	29,743 Added 202.79%	44,410 $4.31 Million
Q2 2018 Aug 13, 2018	BUY	$76.01 - $99.03 $1.11 Million - $1.45 Million	14,667 New	14,667 $1.38 Million
Q3 2017 Nov 14, 2017	SELL	$80.6 - $94.95 $1.64 Million - $1.93 Million	-20,310 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	20,310	20,310 $1.85 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account